# Settlement Inquiry Report

## 1. Decision

**Settlement Inquiry:** Yes  

**Priority:** Medium  

**Recommended Action:** Route to analyst review for manual verification.

**Reason:** The case requires human review due to an unsupported schema and multi-trade ambiguity.

---

## 2. Email Summary

**Email ID:** email_038.eml  
**Subject:** Unknown  
**Sender:** Unknown  
**Received:** Unknown  
**Counterparty:** UBS

The counterparty reports an inconsistency in the booked amount for trade KN56349555.

---

## 3. Classification
- **Primary Type:** wrong_amount (originally amount_mismatch)
- **Multi-type:** false

---

## 4. Multi-Trade Notes
- **Multi-trade Email:** Yes
- **Related Trades:** HD63576518 (Raiffeisen Bank, NVIDIA Corp., USD 2666420.07)

---

## 5. HOST Lookup Comparison

*Note: HOST lookup was not performed as per instructions.*

| Field | Email Value | HOST Value | Status | Severity |
|-------|-------------|------------|--------|----------|
| reference_number | KN56349555 | N/A | N/A | N/A |
| security_isin | null | N/A | N/A | N/A |
| security_name | Roche Holding AG | N/A | N/A | N/A |
| settlement_date | 2026-03-19 | N/A | N/A | N/A |
| trade_date | 2026-03-18 | N/A | N/A | N/A |
| quantity | 68443 | N/A | N/A | N/A |
| amount | 1471393.36 | N/A | N/A | N/A |
| currency | USD | N/A | N/A | N/A |
| side | buy | N/A | N/A | N/A |
| counterparty_name | UBS | N/A | N/A | N/A |
| status | unknown | N/A | N/A | N/A |

### Discrepancy Flags
- **Amount Mismatch:** Sender shows 1748410.65 USD, trade advice quotes 1471393.36 USD.

---

## 5. Findings

The email contains multiple trades and an unsupported schema, requiring human review. There is a reported discrepancy in the booked amount for trade KN56349555 (Sender shows 1748410.65 USD, trade advice quotes 1471393.36 USD).

---

## 6. Next Steps

1. Review the attached `trade_details.zip` to verify the correct amount.

2. Confirm the expected settlement amount with internal records.

3. Reach out to the counterparty to resolve the amount mismatch.

4. Keep the case under analyst review until the discrepancy is resolved.

---